UnknownNot Applicable

ECMO for Critically Ill Patients With Respiratory Failure and/or Circulatory Failure

Thailand250 participantsStarted 2019-07-22

Plain-language summary

Extracorporeal membrane oxygenation (ECMO) had been used to treat refractory hypoxemia associated with acute respiratory distress syndrome (ARDS). There were reported good outcome associated with ECMO for ARDS caused by influenza infection from several ECMO centers. However, the outcome of ECMO support in lower ECMO experience center had not been evaluated. This study aimed to evaluate the outcome of ECMO, comparing with conventional treatment among severe hypoxemic ARDS patients who were admitted in limited ECMO experience hospital.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed ARDS according to Berlin criteria * Refractory hypoxemia: PaO2/FiO2 \<100 with FiO2 \>90% despite optimal mechanical ventilator support and paralytic agent infusion * Hypoxemia persist for at least 2 hours Exclusion Criteria: * Terminally ill patient * Patient who sign for do not resuscitation * Metastatic malignancy

What they're measuring

Hospital outcome

Timeframe: at least 90 days

Trial details

NCT IDNCT04031794

SponsorMahidol University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07-30

Contact for this trial

Surat Tongyoo, Dr.

0820137771 surat.ton@mahidol.ac.th

View on ClinicalTrials.gov More Severe Acute Respiratory Distress Syndrome trials